Biogen Inc. buy Royal Bank of Canada
Start price
19.09.24
/
50%
€180.40
Target price
19.09.25
€262.25
Performance (%)
-37.36%
Price
29.08.25
€113.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is performing very badly with a performance of -37.36%. This prediction currently runs until 19.09.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -4.922% | -4.922% |
iShares Core DAX® | -1.740% | -1.152% |
iShares Nasdaq 100 | -0.157% | -0.813% |
iShares Nikkei 225® | -1.705% | 3.309% |
iShares S&P 500 | 0.148% | 0.240% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $292.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat